OverviewSuggest Edit

ClearPoint Neuro (formerly known as MRI Interventions) is a medical device company. It develops and commercializes platforms for performing minimally invasive surgical procedures in the brain and heart under direct, intra-procedural magnetic resonance imaging guidance. 

TypePublic
Founded1998
HQIrvine, US
Websiteclearpointneuro.com

Latest Updates

Employees (est.) (Mar 2020)21(-44%)
Revenue (FY, 2019)$11.2 M(+53%)
Share Price (Nov 2020)$9.4 (+2%)
Cybersecurity ratingAMore

Key People/Management at ClearPoint Neuro

Joseph M. Burnett

Joseph M. Burnett

Chief Executive Officer
Peter G. Piferi

Peter G. Piferi

Chief Operating Officer
Pascal E.r. Girin

Pascal E.r. Girin

Director
Jeremy Stigall

Jeremy Stigall

Vice President, Biologics & Drug Delivery Development
Harold A. Hurwitz

Harold A. Hurwitz

Chief Financial Officer
B. Kristine Johnson

B. Kristine Johnson

Director
Show more

ClearPoint Neuro Office Locations

ClearPoint Neuro has offices in Irvine and Memphis
Irvine, US (HQ)
5 Musick
Memphis, US
40 S Main St
Show all (2)

ClearPoint Neuro Financials and Metrics

ClearPoint Neuro Revenue

Embed Graph
View revenue for all periods
ClearPoint Neuro's revenue was reported to be $11.22 m in FY, 2019
USD

Revenue (Q2, 2020)

2.5m

Gross profit (Q2, 2020)

1.8m

Gross profit margin (Q2, 2020), %

74.1%

Net income (Q2, 2020)

(1.7m)

EBIT (Q2, 2020)

(1.5m)

Market capitalization (17-Nov-2020)

157.7m

Closing stock price (17-Nov-2020)

9.4

Cash (30-Jun-2020)

16.0m

EV

142.9m
ClearPoint Neuro's current market capitalization is $157.7 m.
Annual
USDFY, 2016FY, 2017FY, 2018FY, 2019

Revenue

5.7m7.4m7.4m11.2m

Revenue growth, %

25%28%0%

Cost of goods sold

2.6m2.9m2.4m3.8m

Gross profit

3.1m4.5m4.9m7.4m
Quarterly
USDQ1, 2017Q2, 2017Q3, 2017Q1, 2018Q2, 2018Q3, 2018Q1, 2019Q2, 2019Q3, 2019Q1, 2020Q2, 2020

Revenue

2.0m2.0m1.7m1.6m1.6m1.8m2.5m2.6m2.9m3.1m2.5m

Cost of goods sold

752.5k798.5k688.8k589.0k602.2k553.2k886.5k1.0m983.0k917.3k640.8k

Gross profit

1.3m1.2m1.0m1.0m1.0m1.3m1.6m1.6m1.9m2.2m1.8m

Gross profit Margin, %

63%60%60%64%63%69%64%60%66%71%74%
Annual
USDFY, 2016FY, 2017FY, 2018FY, 2019

Cash

3.3m9.3m3.1m5.7m

Accounts Receivable

865.9k949.4k1.2m1.1m

Prepaid Expenses

135.0k192.7k213.7k357.2k

Inventories

1.8m2.3m2.1m3.2m
Quarterly
USDQ1, 2017Q2, 2017Q3, 2017Q1, 2018Q2, 2018Q3, 2018Q1, 2019Q2, 2019Q3, 2019Q1, 2020Q2, 2020

Cash

2.0m12.7m11.0m7.5m6.7m3.7m2.5m7.5m6.2m17.0m16.0m

Accounts Receivable

1.0m750.8k863.8k910.1k770.8k1.1m1.3m1.4m2.1m984.9k1.2m

Prepaid Expenses

95.6k270.5k239.3k153.2k321.6k261.9k199.6k430.6k364.3k188.4k537.9k

Inventories

1.8m1.9m2.2m2.5m2.7m2.5m2.0m2.5m3.2m3.7m3.6m
Annual
USDFY, 2016FY, 2017FY, 2018FY, 2019

Net Income

(8.1m)(7.2m)(6.2m)(5.5m)

Depreciation and Amortization

155.7k116.5k109.4k250.6k

Inventories

72.3k(469.9k)122.2k(1.0m)

Accounts Payable

178.4k(512.4k)(284.3k)1.2m
USDFY, 2016

Revenue/Employee

174.2k

Debt/Equity

-2.6 x

Debt/Assets

0.3 x

Financial Leverage

-9.8 x
Show all financial metrics

ClearPoint Neuro Operating Metrics

Nov, 2019

Industry Partners

3

Patent Applications

95

Patents Issued

95
Show all operating metrics

ClearPoint Neuro Acquisitions / Subsidiaries

Company NameDateDeal Size
MRI Interventions (Canada) Inc.

ClearPoint Neuro Revenue Breakdown

Embed Graph

ClearPoint Neuro revenue breakdown by business segment: 9.1% from Service and Other and 90.9% from Product

ClearPoint Neuro Cybersecurity Score

Cybersecurity ratingPremium dataset

A

96/100

SecurityScorecard logo

ClearPoint Neuro Online and Social Media Presence

Embed Graph

ClearPoint Neuro News and Updates

ClearPoint Neuro to Announce Third Quarter 2020 Results on November 10

Release and Call After Market Close Release and Call After Market Close

ClearPoint Neuro Announces Transition Plan for New Chief Financial Officer

Danilo D’Alessandro will Succeed Harold A. Hurwitz who Plans to Retire in 2021 Danilo D’Alessandro will Succeed Harold A. Hurwitz who Plans to Retire in 2021

MRI Interventions, Inc. Announces Uplisting to NYSE American

Stock Will Trade Under Its Existing Symbol ‘MRIC’ Starting July 3, 2019 Stock Will Trade Under Its Existing Symbol ‘MRIC’ Starting July 3, 2019

MRI Interventions Announces Closing of $7.522 Million Private Placement

IRVINE, Calif., May 17, 2019 (GLOBE NEWSWIRE) -- MRI Interventions, Inc. (OTCQB: MRIC) today announced the closing on May 17, 2019 of its previously disclosed private placement of shares of common stock, which resulted in gross proceeds of $7.522 million. The 2,426,455 shares of MRI Interventions’…

MRI Interventions Reports 36% Increase in Fourth Quarter Revenue and Record Quarterly ClearPoint® Cases

Fourth Quarter Cash Burn from Operations Reduced to $600,000 Fourth Quarter Cash Burn from Operations Reduced to $600,000

MRI Interventions, Inc. to Announce Fourth Quarter and Full Year 2018 Results on March 11

IRVINE, Calif., March 06, 2019 (GLOBE NEWSWIRE) -- MRI Interventions, Inc. (OTCQB:MRIC), a platform neurosurgery company with products designed to deliver navigation, ablation, deep brain stimulation, biopsy and gene therapy, today announced that it will release financial results for its 2018 four…
Show more

ClearPoint Neuro Blogs

ClearPoint Neuro Reports First Quarter 2020 Results

Company Provides Update on Effects of COVID-19 Pandemic IRVINE, Calif., May 12, 2020 (GLOBE NEWSWIRE) -- ClearPoint Neuro, Inc. (Nasdaq: CLPT) today announced financial results for its first fiscal quarter ended March 31, 2020. Total revenues were approximately $3.1 million and $2.5 million for…

Corrected: ClearPoint Neuro to Announce First Quarter 2020 Results on May 12

Release and Call After Market Close IRVINE, Calif., May 07, 2020 (GLOBE NEWSWIRE) -- ClearPoint Neuro, Inc. (Nasdaq: CLPT) (the “Company”) today announced that it will release financial results for its 2020 first quarter, which ended March 31, 2020, on Tuesday, May 12, 2020 after the market close…

ClearPoint Neuro to Announce First Quarter 2020 Results on May 12

Release and Call After Market Close IRVINE, Calif., May 07, 2020 (GLOBE NEWSWIRE) -- ClearPoint Neuro, Inc. (Nasdaq: CLPT) (the “Company”) today announced that it will release financial results for its 2020 first quarter, which ended March 31, 2020, on Tuesday, May 12, 2020 after the market close…

ClearPoint Neuro Reports 53% Increase in 2019 Revenue

Fourth quarter revenue grows 41%, fifth consecutive quarter of revenue growth  IRVINE, Calif., Feb. 12, 2020 (GLOBE NEWSWIRE) -- ClearPoint Neuro, Inc. (Nasdaq: CLPT) (formerly, MRI Interventions, Inc.; the “Company”) today announced financial results for its fourth fiscal quarter and full year e…

ClearPoint Neuro to Announce Fourth Quarter and Full Year 2019 Results February 12

Release and Call After Market Close IRVINE, Calif., Feb. 11, 2020 (GLOBE NEWSWIRE) -- ClearPoint Neuro, Inc. (Nasdaq: CLPT) (formerly, MRI Interventions, Inc.; the “Company”, formerly Nasdaq: MRIC) today announced that it will release financial results for its 2019 fourth quarter and full year, w…

MRI Interventions, Inc. Changes Corporate Name to ClearPoint Neuro, Inc.

Company To Commence Trading Under Ticker Symbol CLPT on February 12, 2020 IRVINE, Calif., Feb. 11, 2020 (GLOBE NEWSWIRE) -- MRI Interventions, Inc. (Nasdaq: MRIC) (the “Company”), a leading platform neurosurgery company, will effectuate its previously announced change of its corporate name to Cle…
Show more

ClearPoint Neuro Frequently Asked Questions

  • When was ClearPoint Neuro founded?

    ClearPoint Neuro was founded in 1998.

  • Who are ClearPoint Neuro key executives?

    ClearPoint Neuro's key executives are Joseph M. Burnett, Peter G. Piferi and Pascal E.r. Girin.

  • How many employees does ClearPoint Neuro have?

    ClearPoint Neuro has 21 employees.

  • What is ClearPoint Neuro revenue?

    Latest ClearPoint Neuro annual revenue is $11.2 m.

  • What is ClearPoint Neuro revenue per employee?

    Latest ClearPoint Neuro revenue per employee is $534.1 k.

  • Who are ClearPoint Neuro competitors?

    Competitors of ClearPoint Neuro include Centese, Shoulder Innovations and Filterlex Medical.

  • Where is ClearPoint Neuro headquarters?

    ClearPoint Neuro headquarters is located at 5 Musick, Irvine.

  • Where are ClearPoint Neuro offices?

    ClearPoint Neuro has offices in Irvine and Memphis.

  • How many offices does ClearPoint Neuro have?

    ClearPoint Neuro has 2 offices.